Sakthivel Sadayappan, PhD, MBA
University of Cincinnati, Cincinnati, OH
Dr. Sadayappan’s research is driven by the desire to improve cardiac health with the long-range goal of preventing the development of heart failure that results from hypertrophic cardiomyopathy and coronary heart disease.
For more information, please visit Sadayappan Lab Site.
Elizabeth Murphy, Ph.D.
The Laboratory of Cardiac Physiology, led by Dr. Elizabeth Murphy, studies the molecular mechanisms involved in cardiac cell death, as well as the mechanisms that protect the heart against damage.
For more information, please visit Murphy Lab Site.
Donald Bers, PhD
UC Davis, Davis, CA
Dr. Bers is an internationally renowned leader in cardiovascular research, particularly molecular-cellular and animal studies aimed at understanding regulation of the normal heartbeat and how things go wrong in pathophysiological states like heart failure and arrhythmias.
For more information, please visit Bers Lab Site.
Jil C. Tardiff, MD, PhD
University of Arizona, Tucson, AZ
As a physician-scientist, Dr. Tardiff’s work focuses on the mechanisms that underlie the development of the most common form of genetic cardiomyopathy,hypertrophic cardiomyopathy that has been linked to mutations in genes encoding proteins of the cardiac sarcomere.
For more information, please visit Tardiff Lab Site.
Bjorn C. Knollmann, MD, PhD
Director, Vanderbilt Center for Arrhythmia Research and Therapeutics Vanderbilt University Medical Center, Nashville, TN
Dr. Knollmann investigates the biology of cardiac arrhythmias. Using genetically-altered mice and human induced pluripotent stem cells as model systems, ongoing lab research examines several key pathways of arrhythmias and sudden death in humans. Ongoing clinical studies test new approaches toward preventing atrial fibrillation.
For more information, please visit Knollmann Lab Site.
Steven R. Houser, PhD
Temple University, Philadelphia, PA
The research in the Houser laboratory is focused on those processes thatmaintain the electrical and contractile properties of the normal heart andthe defects in these processes that lead to electrical instability (arrhythmias and sudden death), poor cardiac pump performance and congestive heart failure).
For more information, please visit Houser Lab Site.
James N. Weiss, MD
UCLA Medical Center, Los Angeles, CA
Dr. Weiss’ research focuses on ion channel biophysics, cardiac electrophysiology, arrhythmias, and ischemia and mitochondrial biology. He leads an interdisciplinary group combining mathematical and experimental biology.
For more information, please visit Weiss Lab Site.
Paul D. Allen, MD, PhD
Professor of Anaesthesia, Emeritus
Eduardo Marbán, MD, PhD
Cedars-Sinai, Los Angeles, CA
The current research areas of Dr. Marbán are using biologically based therapies for cardiac regeneration and biological pacemakers.
For more information, please visit Marbán Lab Site.
Martin Morad, PhD
Medical University of South Carolina, Charleston, SC
Dr. Morad is an internationally recognized scientist in the field of cardiac electrophysiology and calcium signaling, specifically in the area of calcium-binding proteins.
For more information, please visit Morad Lab Site.
James D. Potter, PhD
University of Miami Miller School of Medicine, Miami, FL
The Cardiac Muscle Society was established in the 1960’s to promote the interactions between basic and clinical cardiovascular investigators. Members meet annually, exchange their latest discoveries and exchange ideas on future cardiovascular research.
231 Albert Sabin Way, Room 4978
Cincinnati, Ohio, 45267
Phone: (513) 558-7442